⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 1, 2025

Supplemental Figure 3 from A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy

Debarati Bhanja Junjia Zhu Hannah Wilding Jorge Benavides‐Vasquez Leonardo de Macêdo Filho Ahmad Ozair Camille Moeckel Aarav Badani Jinpyo Hong Jeffrey Sivik Joseph J. Drabick Colette R. Pameijer Kim Margolin Manmeet S. Ahluwalia Alireza Mansouri

View at Publisher

Ask AI

Bookmark

Share

Key Points

The analysis focuses on melanoma brain metastasis after dual-agent immunotherapy.
It reports treatment side effect incidences across three different cohorts of patients.
The dIT cohort received specific immunotherapy doses tracked for outcomes.
These findings could influence future treatment strategies for melanoma patients.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Real-world analysis reveals immunotherapy doses and treatment side effect incidences in melanoma cohorts.

Abstract

Supplemental Figure 3 shows the immunotherapy doses received in the dIT cohort and the treatment side effect incidences among all three cohorts.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bhanja et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d0152 https://doi.org/10.1158/1078-0432.29760953

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplemental Figure 2 from A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy2025
2Supplemental Table 2 from A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy2025
3Supplemental Figure 1 from A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy2025
4Supplemental Table 1 from A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy2025
5Data from A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy2025

A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy2025
Supplementary Data S2 from Spatially Informed Gene Signatures for Response to Immunotherapy in Melanoma2024
Supplementary Data S2 from Spatially Informed Gene Signatures for Response to Immunotherapy in Melanoma2024